Sania Therapeutics to Present at the American Society of Gene & Cell Therapy Annual Meeting
11. April 2024 07:00 ET
|
Sania Therapeutics
Sania Therapeutics to Present at the American Society of Gene & Cell Therapy Annual Meeting LONDON, UK & NEW YORK, USA – 11 April 2024, Sania Therapeutics (the “Company”), focused on...
PathMaker Neurosystems Receives $200,000 START Award from MassVentures
05. Juni 2023 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON, June 05, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
07. März 2022 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Intrathecal Pumps Market Size ($513.24Mn by 2028) Growth Forecast at 5.3% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com
07. Oktober 2021 07:08 ET
|
The Insight Partners
New York, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Intrathecal Pumps Market: Key InsightsAccording to our new research study on “Intrathecal Pumps Market to 2028 – Global Analysis and Forecast – by Type,...
PathMaker Neurosystems Announces Completion of Pivotal European Clinical Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
27. September 2021 05:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 27, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
PathMaker Neurosystems Welcomes Healthcare Veteran Terri Bresenham to Board of Directors
15. Juli 2020 07:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, July 15, 2020 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing breakthrough non-invasive technology for the...
PathMaker Neurosystems Appoints Medtech Industry Veteran Hooman Hakami as Chairman of Company’s Board of Directors
14. Mai 2020 07:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, May 14, 2020 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company developing breakthrough non-invasive systems for the treatment...